Publications
-
Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED and Hollenbach JA.
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
ANNALS OF THE RHEUMATIC DISEASES . 81(3): 406-415. Number of citations: 61
-
Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, Sztajnbok F, Terreri MT, Anton-Lopez J, Smith V, Katsicas M, Kostik M, Vasquez-Canizares N, Avcin T, Feldman B, Janarthanan M, Santos MJ, Sawhney S, Schonenberg-Meinema D, Sifuentes-Giraldo WA, Alexeeva E, Appenzeller S, Battagliotti C, Berntson L, Bica B, Costa Reis P, Eleftheriou D, Kallinich T, Lehman T, Marrani E, Minden K, Nielsen S, Nuruzzaman F, Patwardhan A, Khubchandani R, Stanevicha V, Uziel Y and Torok KS.
Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis
ARTHRITIS CARE & RESEARCH . 74(3): 364-370. Number of citations: 11
-
Zanetti SR, Velasco-Hernandez T, Gutierrez-Agüera F, Díaz VM, Romecín PA, Roca-Ho H, Sánchez-Martínez D, Tirado N, Baroni ML, Petazzi P, Torres-Ruiz R, Molina O, Bataller A, Fuster JL, Ballerini P, Juan-Otero M, Jeremias I, Bueno C and Menéndez P.
A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL
MOLECULAR THERAPY . 30(2): 550-563. Number of citations: 25
-
Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton-Lopez J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M and Semerano LR.
The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort
SEMINARS IN ARTHRITIS AND RHEUMATISM . 52: 151957-151957. Number of citations: 6
-
Grasa CD, Fernández-Cooke E, Sánchez-Manubens J, Carazo-Gallego B, Aracil-Santos J, Anton-Lopez J, Lirola MJ, Mercader B, Villalobos E, Bustillo M, Giralt G, Rocandio B, Escribano LM, Domínguez-Rodríguez S and Calvo C.
Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort
EUROPEAN JOURNAL OF PEDIATRICS . 181(2): 589-598. Number of citations: 4
-
Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Schmid JP, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králícková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue-Salvador T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD and Grimbacher B.
Therapeutic options for CTLA-4 insufficiency
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 149(2): 736-746. Number of citations: 71
-
Girona M, Argüello G, Esteve-Solé A, Bobillo-Perez S, Paolo-Burgos X, Bonet E, Mensa-Vilaró A, Codina-Bergadà A, Hernández-Garcia M, Jou-Munoz C, Alsina L and Jordán-García I.
Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
iScience . 25(1): 103595-103595. Number of citations: 2
-
Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth D, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A and Lin J.
A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
JOURNAL OF CLINICAL IMMUNOLOGY . 42(3): 500-511. Number of citations: 5
-
Alsina L, Montoro JB, Moral PM, Neth O, Pica MO, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MÁ and González-Granado LI.
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
EUROPEAN JOURNAL OF HEALTH ECONOMICS . 23(3): 551-558. Number of citations: 13
-
Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibáñez-Micó S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Solé A, Alsina L, Corral J and Hernández-Caselles T.
Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies
Glycobiology . 32(2): 84-100. Number of citations: 4